

Elutia (NASDAQ:ELUT) reported third-quarter financial results on Thursday. The transcript from the company’s third-quarter earnings call has been provided...
You can purchase shares of Elutia (NASDAQ:ELUT) through any online brokerage.
Other companies in Elutia’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Elutia has a consensus price target of $7.00.
The stock price for Elutia (NASDAQ: ELUT) is $0.7659 last updated November 6, 2026 at 7:21 AM EST.
There are no upcoming dividends for Elutia.
Elutia does not have any upcoming earnings scheduled.
There is no upcoming split for Elutia.
Elutia is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Elutia Inc develops proprietary drug-eluting biomatrix products for use in surgical reconstruction and related applications. These products are designed to improve the interaction between implanted medical devices and patients. Its products include...